Skip to main content
Home
  • Get Updates
  • Members and Providers
    • Member
    • Provider
      • Who We Serve: Overview
      • Consultants
      • Employers
      • Federal
      • Health Plans
      • Hospitals and Health Systems
      • Labor Unions
      • Public Sector
      • Members
      • Providers
      • Health Plans
      • Employers
      • Consultants
      • Labor Unions
      • Federal
      • Public Sector
      • Hospitals & Health Systems
      • Providers
      • Lower Costs
      • Improve Outcomes
      • Expand Access
      • Increase Member Engagement
      • Musculoskeletal
      • Behavioral Health
      • Oncology
      • Cardiovascular Disease
      • Diabetes
      • Obesity
      • Women’s Health and Family Planning
      • Pharmacy
      • Specialty
      • Express Scripts by Evernorth
      • Express Scripts Pharmacy by Evernorth
      • Accredo by Evernorth
      • EviCore by Evernorth
      • CuraScript SD by Evernorth
      • MyMatrixx by Evernorth
      • Freedom Fertility by Evernorth
      • MD Live by Evernorth
      • Insights
      • Newsroom
      • Behavioral Health
      • Gene Therapy
      • GLP-1s
      • Health Equity
      • Oncology
      • Women's Health
      • Health Care in Focus
      • Importance of Vitality
      • Pharmacy in Focus
      • Women's Health Report
      • Youth Mental Health
      • Evernorth Research Institute
      • The Lab by Evernorth
    • Why Evernorth?
    • About Us
    • Careers
  • Get Updates
  • Members and Providers
    • Member
    • Provider
Close search filters
info
Changing filters will change the listed Success Criteria and Techniques

Category
  • (-) All Results
  • article (3)

Topic
  • Accredo
  • CuraSciptSD
  • eviCore
  • (-) Express Scripts PBM
  • Express Scripts Pharmacy
  • Freedom Fertility
  • Inside Rx
  • MDLIVE

Search results (3)
Filter By
Article
Three specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs
April 20, 2022
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...
Read more
Article
Copay Assistance Strategy Reduces Financial Burdens for Plans And Patients
October 07, 2021
Innovative solution provides $0 member cost for costly specialty drugs while reducing plans’ costs
Read more
Video
Biosimilar Approval and Adoption Challenges
June 10, 2022
Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.
Read more
Home

Footer Column 1

  • Solutions
  • News and Insights
  • Press Releases
  • Careers
  • About Us
  • Accreditation
  • Contact Us

Footer Column 2

  • Express Scripts by Evernorth
  • Express Scripts Pharmacy by Evernorth
  • Accredo by Evernorth
  • Freedom Fertility by Evernorth
  • EviCore by Evernorth
  • MyMatrixx by Evernorth

Footer Column 3

  • CuraScript SD by Evernorth
  • Evernorth Behavioral Care Group
  • Evernorth Care Group
  • Inside Rx
  • MD Live by Evernorth
Facebook Logo Instagram Logo Linkedin Logo YouTube Logo

 

Language Assistance

Español [PDF]  |  中文 [PDF]  |  Tiếng Việt [PDF]  |  한국어 [PDF]  |  Tagalog [PDF]  |  Русский [PDF]   |  العربية [PDF]  |  Kreyòl [PDF]

Français [PDF]  |  Português [PDF]  |  Polski [PDF]  |  日本語 [PDF]  |  Italiano [PDF]  |  Deutsch [PDF]  |  فارسی [PDF]  |  More… [PDF]

 

Availability of programs and services may vary by location and is subject to change.

© 2025 Evernorth Health, Inc. All rights reserved. One Express Way, St. Louis, MO 63121
All products and services are provided by or through operating subsidiaries or affiliates of Evernorth.

 

Terms of Use Privacy Notice Notice of Privacy Practices

Accessibility   Health Care Fraud   Nondiscrimination Notice    WA Consumer Health Data Privacy Notice

View all Evernorth Privacy Notices